A noncontrolled phase I study in recurrent metastatic glioblastoma showed 3-year survival was five times higher in patients treated with intratumoral PVSRIPO.
Melanoma patients who were treated with glucocorticoids for ipilimumab-induced hypophysitis had improved survival outcomes if they received low doses.
MGH Program Supports Sexual Health of Women Receiving Pelvic RT for Gastrointestinal and Gynecologic Malignancies
In an interview with Cancer Network, Lorraine Drapek describes a multidisciplinary program at MGH to support vaginal and sexual health post RT for GI and gynecologic malignancies.
Patients with muscle-invasive bladder cancer who underwent trimodal therapy had significantly poorer survival than those who underwent radical cystectomy alone.
TROG 99.03 constitutes “the only high level evidence currently available to guide decision making for this group of patients,” says investigator Michael MacManus.
In addition to significant improvements in 5-year OS and PFS with maintenance rituximab, there was a trend toward an association between maintenance and reduced transformation risk.
Germline BRCA mutations and other HR genes may offer biomarkers for response to this treatment.
Oncology nurse leaders share insights into the care of vulnerable oncology populations—from ED triage to tailored telehealth sessions for homeless populations.
Overexpression of IKZF1 facilitates immune attack on skin cancer and other solid tumors.
A team from Children’s Healthcare of Atlanta reports unexpected factors determining which adolescents participated in sperm banking.